Revolutionizing Genitourinary Diagnostics
Non-invasive genitourinary diagnostics for unmet clinical needs


Kidney chronic diseases
are mainly diagnosed and monitored by means of imaging tests and biopsies.


4% Complication Rate
20% Patients refuse diagnostic
Frequently unconclusive
3% Annual healthcare cost
15% World's population affected
30M Undiagnosed cases/year (only in US)
It is time for a revolution
Early diagnostic.
Better patient management.
We help clinicians in early-diagnosing and monitoring genitourinary diseases such as Chronic Kidney Disease (CKD), Kidney transplant failure and many others our R&D team continuously investigates.
Our main benefits to the clinician and healthcare community
Non-invasive diagnostics while improving the trustability of diagnostic
Earlier disease detection than current Standard of Care
Better monitoring process allowing for personalized patient management
Our leading team


Marta Clos, MSc.
CTO & co-founder - IVD Technology director
Francesc E. Borràs, PhD.
CSO & co-founder - Scientific director. R&D team management
Albert Mascarell, MBA
CEO & co-founder - Business administration
Clinical Advisory board
Industry Advisory board


Jordi Bover, MD
KOL and head of nephrology at HUGTP. DEBIOS Advisory Board Director & co-founder


R. Lauzurica, MD
KOL with +40 years clinical experience with kindney transplants


Marta Palicio PhD
Innovation R&D Director at Werfen


Nuria Pascual PhD
Technical Director CAbs


DEBIOS Diagnostics is a spin-off company from the Germans Trias i Pujol Research Institute.